Benzinga · Aug 19, 2026
DNA X Q2 EPS $(0.91) Up From $(14.15) YoY
DNA X (NASDAQ:SONM) reported quarterly losses of $(0.91) per share. This is a 93.57 percent increase over losses of $(14.15) per share from the same period last year.

NASDAQ · SONM
Technology · Communication Equipment
$3.99
Down-$0.04 (-0.87%)
Updated Oct 7, 2026, 3:17 AM
SID Score
4.6/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance · SONM
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 6, 2026
SONM closed at $3.99 after 21 trading sessions, up 27.48% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 6, 2026 | $4.11 | $4.25 | $3.87 | $3.99 | 16.2K |
| Oct 5, 2026 | $4.06 | $4.15 | $3.965 | $4.025 | 3.71K |
| Oct 2, 2026 | $4.14 | $4.3198 | $3.99 | $4.08 | 7.8K |
| Oct 1, 2026 | $4.565 | $4.565 | $4.145 | $4.145 | 9.37K |
| Sep 30, 2026 | $4.17 | $4.75 | $4.17 | $4.565 | 15.07K |
| Sep 29, 2026 | $4.33 | $4.35 | $4.0301 | $4.19 | 18.53K |
| Sep 28, 2026 | $4.02 | $4.43 | $3.935 | $4.35 | 44.51K |
| Sep 25, 2026 | $4.02 | $4.06 | $3.915 | $3.915 | 6.73K |
| Sep 24, 2026 | $3.60 | $4.00 | $3.60 | $3.95 | 8.93K |
| Sep 23, 2026 | $4.175 | $4.175 | $3.6101 | $3.6101 | 24.52K |
| Sep 22, 2026 | $4.15 | $4.48 | $4.00 | $4.39 | 67.71K |
| Sep 21, 2026 | $3.5015 | $4.1999 | $3.5015 | $4.05 | 96.21K |
| Sep 18, 2026 | $3.02 | $3.60 | $3.01 | $3.46 | 39.21K |
| Sep 17, 2026 | $3.15 | $3.15 | $2.9456 | $2.96 | 7.05K |
| Sep 16, 2026 | $3.00 | $3.20 | $2.97 | $3.03 | 21.16K |
| Sep 15, 2026 | $3.025 | $3.03 | $2.86 | $3.02 | 6.6K |
| Sep 14, 2026 | $3.11 | $3.14 | $3.0652 | $3.0652 | 3.55K |
| Sep 11, 2026 | $3.1509 | $3.16 | $2.99 | $3.16 | 15.57K |
| Sep 10, 2026 | $3.20 | $3.20 | $3.0926 | $3.17 | 4.92K |
| Sep 9, 2026 | $3.2113 | $3.2113 | $3.03 | $3.13 | 6.24K |
| Sep 8, 2026 | $3.1234 | $3.22 | $3.0292 | $3.13 | 10.43K |
The latest Smart Investors Daily articles mentioning SONM.
Company
Market Activity
Research & News
SONM research
Company profile and research snapshot.
Sonim Technologies Inc is a provider of ultra-rugged mobile devices, including phones and accessories designed specifically for task workers physically engaged in their work environments, often in mission-critical roles. The company sells mobile phones, accessories, and solutions to AT&T, T-Mobile, and Verizon in the Canada, and to Bell, Rogers, and Telus and Rogers, Telstra in Australia. The products include rugged mobile phones that can attach to both public and private wireless networks, industrial-grade accessories that meet the requirements of specific applications and software applications, and cloud-based tools that provide management and deployment services to customers. The company generates revenue from discounts, price protection, and customer incentives.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| May 14, 2020 | B. Riley FBR | Buy | — |
| Oct 31, 2019 | Oppenheimer | Perform | — |
| Sep 11, 2019 | B. Riley | Buy | — |
| Jul 18, 2019 | B. Riley FBR | Buy | — |
| Jul 9, 2019 | National Securities | Buy | — |
No generated briefing is available yet.
Benzinga · Aug 19, 2026
DNA X (NASDAQ:SONM) reported quarterly losses of $(0.91) per share. This is a 93.57 percent increase over losses of $(14.15) per share from the same period last year.
Benzinga · Jul 6, 2026
Gainers Lianhe Sowell Intl (NASDAQ:LHSW) stock rose 187.2% to $5.17 during Monday's pre-market session. The market value of their outstanding shares is at $5.8 million. UTime (NASDAQ:FXHO) stock moved upwards by
Benzinga · Jul 2, 2026
On June 29, 2026, DNA X, Inc. (the "Company") entered into a securities purchase agreement (the "Purchase Agreement") with DNA Holdings Venture, Inc. ("DNA Holdings"), a holder of more than 5% of
Benzinga · Jun 26, 2026
Gainers PicoCELA (NASDAQ:PCLA) shares rose 108.8% to $6.41 during Friday's regular session. The company's market cap stands at $29.5 million. Hitek Global (NASDAQ:HKIT) shares moved upwards by 35.75% to $0.3.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.


The latest Smart Investors Daily articles mentioning SONM.